However, CCL5 and anti-CCL5 antibodies rarely affect the tumor-inhibiting effect induced by PTBP2, leading us to hypothesize that PTBP2-attracted monocytes and Mφs may exert their main antitumor effects through other mediators. The gene discussed is CCL5; the disease is neoplasm.